Old Mission Capital LLC Evotec Se Transaction History

Old Mission Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.33 - $11.89 $100,118 - $142,905	12,019 New	12,019 $140,000
Q1 2023 May 12, 2023	SELL	$8.11 - $10.53 $91,715 - $119,083	-11,309 Reduced 46.09%	13,226 $138,000
Q4 2022 Feb 14, 2023	BUY	$7.8 - $9.85 $191,373 - $241,669	24,535 New	24,535 $198,000
Q2 2022 Aug 05, 2022	SELL	$10.78 - $15.5 $419,697 - $603,461	-38,933 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.93 - $23.46 $503,403 - $913,368	38,933 New	38,933 $589,000

3.42M

Ticker EVO
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 353,904,992
Market Cap $1.58B
Description
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.